Compare, Analyse Cipla with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CIPLA   ACTAVIS
EQUITY SHARE DATA
    CIPLA
Mar-20
ACTAVIS
Dec-18
CIPLA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs58614,406-   
Low Rs3579,664-   
Sales per share (Unadj.) Rs212.53,533.8-  
Earnings per share (Unadj.) Rs19.2-1,138.2-  
Cash flow per share (Unadj.) Rs32.8372.4-  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs194.914,575.3-  
Shares outstanding (eoy) m806.24332.60-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.23.4 65.1%   
Avg P/E ratio x24.6-10.6 -232.2%  
P/CF ratio (eoy) x14.432.3 44.4%  
Price / Book Value ratio x2.40.8 292.8%  
Dividend payout %20.80-   
Avg Mkt Cap Rs m379,8584,002,789 9.5%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m30,2700-   
Avg. sales/employee Rs ThNM69,546.9-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-22,401.1-  
INCOME DATA
Net Sales Rs m171,3201,175,342 14.6%  
Other income Rs m3,69422,476 16.4%   
Total revenues Rs m175,0141,197,819 14.6%   
Gross profit Rs m31,06130,800 100.8%  
Depreciation Rs m11,000502,433 2.2%   
Interest Rs m1,97467,824 2.9%   
Profit before tax Rs m21,782-516,981 -4.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0131,851 0.0%   
Tax Rs m6,312-6,552 -96.3%   
Profit after tax Rs m15,470-378,578 -4.1%  
Gross profit margin %18.12.6 691.9%  
Effective tax rate %29.01.3 2,286.7%   
Net profit margin %9.0-32.2 -28.0%  
BALANCE SHEET DATA
Current assets Rs m117,062482,064 24.3%   
Current liabilities Rs m43,931426,450 10.3%   
Net working cap to sales %42.74.7 902.1%  
Current ratio x2.71.1 235.7%  
Inventory Days Days5020 255.7%  
Debtors Days Days8366 125.0%  
Net fixed assets Rs m117,166133,042 88.1%   
Share capital Rs m1,6130-   
"Free" reserves Rs m155,4870-   
Net worth Rs m157,1004,847,737 3.2%   
Long term debt Rs m23,6931,707,064 1.4%   
Total assets Rs m234,2287,578,117 3.1%  
Interest coverage x12.0-6.6 -181.8%   
Debt to equity ratio x0.20.4 42.8%  
Sales to assets ratio x0.70.2 471.6%   
Return on assets %7.4-4.1 -181.6%  
Return on equity %9.8-7.8 -126.1%  
Return on capital %13.1-4.8 -271.4%  
Exports to sales %32.20-   
Imports to sales %3.40-   
Net fx Rs m50,1330-   
CASH FLOW
From Operations Rs m30,685419,905 7.3%  
From Investments Rs m1,040230,683 0.5%  
From Financial Activity Rs m-29,488-720,683 4.1%  
Net Cashflow Rs m2,340-69,745 -3.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 74.45 Rs / USD

Compare CIPLA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare CIPLA With: KERALA AYURV  FERMENTA BIOTECH  AVON ORGANIC  HINDUSTAN BIOSCIE  MESCO PHARMA  



Today's Market

Sensex Ends 139 Points Higher; ICICI Bank, Wipro and ITC Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views On News

Cipla's New Covid-19 Drug to Be Sold at Rs 59,750 Per Dose (Views On News)

May 25, 2021

The first batch of Roche's antibody cocktail has been launched in India, with the second batch to be made available by mid-June.

Cipla's Q4 Update: Net Profit Surges 68%; Company to Pay Rs 5 Dividend (Views On News)

May 17, 2021

Here's a rundown on the latest quarterly results of Cipla.

CIPLA Announces Quarterly Results (3QFY21); Net Profit Up 112.8% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, CIPLA has posted a net profit of Rs 8 bn (up 112.8% YoY). Sales on the other hand came in at Rs 52 bn (up 18.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

More Views on News

Most Popular

A 25 Bagger Indian Stock at the Centre of the Global Semiconductor Chip Shortage (Profit Hunter)

Jul 13, 2021

One technology company in India is grossly underrated despite its dominant role in semiconductor chip designing.

RBI Opens a New Market for Investors (Fast Profits Daily)

Jul 16, 2021

You now have a new way to create wealth. Grab it with both hands.

OPEC is Dying! RIP OPEC (Fast Profits Daily)

Jul 13, 2021

Why the global oil cartel is unravelling and how India stands to gain.

Top 4 Companies that Are Strong Monopolies (Views On News)

Jul 10, 2021

A close look at the top 4 companies with a dominant position in their industry.

A Better Way than the Zomato IPO to Play the Food Delivery Megatrend (Profit Hunter)

Jul 14, 2021

A unique backdoor way of making big profits from smallcap companies.

More
-->

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

CIPLA SHARE PRICE


Jul 23, 2021 (Close)

TRACK CIPLA

MORE ON CIPLA

CIPLA 5-YR ANALYSIS

COMPARE CIPLA WITH

FEATURED VIDEOS

What is the Best Time to Sell a Stock?

What Will Make You Rich Faster: Investing or Trading?

CRISIL v/s CARE Ratings: An Interesting Comparison

The 3-Word Secret to Earning Incredible Returns

More Featured Videos

MARKET STATS